Beyond Air (NASDAQ:XAIR) Earns “Buy” Rating from D. Boral Capital

Beyond Air (NASDAQ:XAIR)‘s stock had its “buy” rating restated by stock analysts at D. Boral Capital in a note issued to investors on Friday,Benzinga reports. They presently have a $10.00 price target on the stock.

XAIR has been the subject of several other reports. Weiss Ratings reissued a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. Rodman & Renshaw initiated coverage on Beyond Air in a report on Tuesday, January 20th. They issued a “buy” rating on the stock. Finally, Wall Street Zen upgraded Beyond Air to a “sell” rating in a research report on Saturday, March 7th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $10.00.

Beyond Air Stock Up 4.7%

NASDAQ XAIR opened at $0.72 on Friday. Beyond Air has a 12 month low of $0.67 and a 12 month high of $5.84. The company has a market capitalization of $7.61 million, a P/E ratio of -0.13 and a beta of 0.41. The company has a debt-to-equity ratio of 2.65, a current ratio of 5.12 and a quick ratio of 4.77. The company’s 50 day simple moving average is $1.05 and its 200 day simple moving average is $1.46.

Beyond Air (NASDAQ:XAIR) last released its quarterly earnings results on Friday, February 13th. The company reported ($0.85) EPS for the quarter, missing the consensus estimate of ($0.54) by ($0.31). Beyond Air had a negative net margin of 447.75% and a negative return on equity of 268.82%. The company had revenue of $2.19 million for the quarter, compared to the consensus estimate of $2.15 million. Equities research analysts expect that Beyond Air will post -0.79 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Alpine Global Management LLC bought a new stake in Beyond Air in the third quarter valued at approximately $25,000. Virtu Financial LLC bought a new position in shares of Beyond Air during the third quarter worth $48,000. Geode Capital Management LLC grew its holdings in shares of Beyond Air by 57.5% in the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after buying an additional 24,695 shares during the period. Osaic Holdings Inc. grew its holdings in shares of Beyond Air by 26.4% in the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after buying an additional 34,000 shares during the period. Finally, Alyeska Investment Group L.P. bought a new stake in shares of Beyond Air in the 3rd quarter valued at $1,753,000. Institutional investors and hedge funds own 31.50% of the company’s stock.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.